Add 'Clinical effectiveness results The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation NCBI Bookshelf'
master
commit
d5e533bc9e
1 changed files with 11 additions and 0 deletions
Unified View
Diff Options
11
Clinical-effectiveness-results-The-effects-and-safety-of-testosterone-replacement-therapy-for-men-with-hypogonadism%3A-the-TestES-evidence-synthesis-and-economic-evaluation-NCBI-Bookshelf.md
11
Clinical-effectiveness-results-The-effects-and-safety-of-testosterone-replacement-therapy-for-men-with-hypogonadism%3A-the-TestES-evidence-synthesis-and-economic-evaluation-NCBI-Bookshelf.md
@ -0,0 +1,11 @@ |
|||||
|
<br> |
||||
|
<br>Other studies followed, stating the relationship between erectile dysfunction and LUTS and TTh alone or in combination with α-blockers or phosphodiesterase type 5 inhibitors (PDE-5i) can improve both erectile dysfunction and LUTS . These results suggest that TRT might have a protective effect against high-grade prostate cancer 21,22. The authors found that the incidence of positive prostate biopsies was lowest in hypogonadal men receiving TRT and with lower prostate cancer severity in terms of staging. |
||||
|
In recent years, the idea of naturally boosting testosterone that’s lost due to aging, obesity, or lifestyle choices such as drinking alcohol has gained attention. Low "T," as testosterone is often called, can impair health in several ways, including increasing the risk of erectile dysfunction and even depression. After you reach 30 years old, testosterone declines by about 1% a year. |
||||
|
Another study looking at the effect of red clover on the quality of life, and sexual function in men found that this supplement did not change sexual or erectile function, and resulted in a significant increase in liver transaminases . There is often the hope that supplements will increase T in a more "natural" manner, and therefore be free from risk. Herbal supplements designed to increase T are poorly studied yet remain popular among aging men who seek to increase their T without standard TRT. Given these findings, 15 individual supplements (13.8%) therefore had conflicting data regarding their effect on T. Eleven individual supplements (10.1%) had data showing a decrease in T with supplementation, and 20 individual supplements (18.3%) had data showing no change in T with supplementation. For 13 supplements (11.9%) there were 2 studies; for 3 supplements (2.8%) there were 3 studies; for 4 supplements (3.7%) there were 4 studies; for 1 supplements (0.9%) there were 5 studies; for 1 supplements (0.9%) there were 6 studies. |
||||
|
First, the participants of studies included in the present analysis were selected on the basis of their androgen status, as opposed to their health status or symptoms. A meta-analysis was therefore conducted of 16 RCTs on aging men with primary or secondary hypogonadism to assess the efficacy and safety of TRT. Numerous clinical trials have examined the efficacy and safety of TRT for men with [buy testosterone cream online](http://8.131.93.145:54082/louveniaz42356) deficiency based on serum levels (6–21); however, paradoxical results have prevented conclusions from being made. A total of 6 RCTs, involving 1,351 participants (775 in the testosterone group and 576 in the control group), reported upon the number of serious adverse events. A total of 6 RCTs, involving 1,351 participants (775 in the testosterone group and 576 in the control group), included details of mild to moderate adverse events (Table II). |
||||
|
Prior to interruption, TRT resulted in improvements in residual voiding volume, bladder wall thickness, CRP, AMS, IIEF-EF, IPSS and obesity parameters, while PSA and prostate volume increased. Prostate volume, PSA, residual voiding volume, bladder wall thickness, C-reactive protein (CRP), Aging Males’ Symptoms (AMS) scale, International Index of Erectile Function-erectile function (IIEF-EF) and IPSS were measured over the study period with anthropometric parameters of obesity, including weight, [jobbridge4you.com](https://jobbridge4you.com/employer/association-between-the-oxidative-balance-score-and-testosterone-deficiency-a-cross-sectional-study-of-the-nhanes-2011-2016-scientific-reports/) body mass index and waist circumference. This study recommended that with careful monitoring, [buy testosterone online](http://121.181.234.77/bbs/board.php?bo_table=blessed_pray&wr_id=1372425)-deficient patients with T2DM and cardiovascular risk may benefit from TRT. Until recently, there was no indication that men with type I DM had subnormal serum testosterone levels. |
||||
|
Numerous studies have shown the benefits of TTh overtly in hypogonadal men. TTH might improve irritative and obstructive symptoms independent from prostate size . It becomes apparent that [buy testosterone steroids](http://120.26.116.243:3000/latoshalindgre) is not only significant for the formation of male urogenital anatomical structure prenatally, their growth and functioning at the time of puberty but that these structures also need testosterone for maintaining their normal functioning. Testosterone augments the action of NO and therefore testosterone might be helpful in men with LUTS who are testosterone deficient. |
||||
|
Peptides are amino acid chains that occur naturally in your body and some foods, while anabolic steroids are artificial hormones. However, since supplements aren’t regulated by the FDA, it’s not always possible to determine the type, quantity, and quality of the ingredients in a product. Peptide supplements are generally considered safe because they’re often made by isolating naturally occurring peptides in food. Consider speaking with a doctor before taking peptide supplements if you’re pregnant, breastfeeding, taking any medications, or have a certain health condition. Doing so may carry some risks, as the long-term safety of these supplements is unclear, and it’s virtually impossible to evaluate the quality of the purchased supplement.. Park et al. conducted a similar study by administering oral testosterone undecanoate in a single-blind, placebo-controlled study to 33 participants with hypogonadism. The study noted a significant increase in mean serum PSA levels in the 100 mg T gel group, going from (0.89±0.08) ng/mL upon the initial measurement on day 0 to (1.19±0.12) ng/mL on day 90.|In studies demonstrating heterogeneity, a sensitivity analysis was conducted in order to establish the cause of heterogeneity. I2 metric was used to quantify heterogeneity, which is independent of the number of studies included in the cumulative analysis. All included studies were required to provide treatment of the subjects for at least 6 months. Only placebo-controlled, randomized controlled trials (RCTs) of men with testosterone deficiency that compared TRT-treated with placebo-treated patients were included.|A prospective data study on 553 patients who underwent prostate biopsy to investigate the role of TRT in prostate safety and cancer progression. Other studies investigated the effects of TRT in patients who had prostate cancer especially those who were diagnosed with prostate cancer but untreated. Most of these studies found that increased testosterone even over the long term does not affect PSA or its effect to be negligible 12–15. For a long time, it was believed that higher testosterone concentrations increased the risk of prostate cancer or caused rapid cancer growth, while low testosterone concentrations would have a protective outcome.|However, despite this FDA statement, the "T booster" supplements made a host of claims. Relatively low levels of zinc over-supplementation have been shown to interfere with the utilization of copper and iron and to adversely affect high-density lipoprotein cholesterol concentrations. It is worrisome that two supplements had greater than the UL of zinc. However, it is even more concerning that some of these supplements may in fact decrease serum T. It is unclear why companies would include components in their supplements that have no evidence to support their use. Of concern, 10.1% of components had published data that found a decrease in T with supplementation. However, for many of these (15 of the 27, or 55.5%) there was also conflicting data showing no change or a decrease in T with supplementation.|No significant changes in liver function tests were noted in the previously mentioned Wang et al. study comparing T gel uses of 50 mg, 100 mg, and T patch; however, measured PSA levels throughout treatment did show significant changes. The patient had developed precocious puberty due to the transfer of [buy testosterone injections](https://play.mytsi.org/@kitestell55246?page=about) from the patient's father, who had been undergoing treatment for hypogonadism using a topical gel. In a separate meta-analysis by Giovanni Corona et al., a study conducted with more than 700 patients using a transdermal delivery method showed a significant improvement in the patient's sexual function . Measurements of lean body mass and fat mass were recorded by Wang et al., in the T gel 50mg/day group an increase in lean body mass of (1.59 ± 0.39) kg was seen after 180 days. In J. Rodriguez-Tolra et al.'s previously mentioned study, total bone mass density was also measured during months 12 and 24 in the lumbar spine, femur, trochanter, and Ward's triangle using a DEXA scan. In a study by Raynaud et al., there was an elevated prostate-specific antigen (PSA) level due to IM testosterone over six years . In a study by Turner et al., patients experienced pain at the injection site up to 24 hours after treatment .} |
||||
|
Only including participants with [buy testosterone online no prescription](https://git.danpeak.co.uk/latialeonski59) Purple line – significant threshold; yellow line and shading – mean IIEF-15 levels above, below or between thresholds. Scatterplots of IIEf-15 during testosterone vs. (a) patient age; (b) serum baseline TT; (c) BMI. Subgroup analysis for IIEF-15 and its subscales Two-stage meta-analysis for Male Sexual Health Questionnaire-Ejaculatory Dysfunction-Short Form. |
||||
|
Subgroup analysis indicated that there were no significant differences in IPSS in long-term or short-term treatment. A total of 7 RCTs, involving 893 participants (479 in the testosterone group and 414 in the control group), provided IPSS. BMI measurements were included in 6 RCTs, involving a total of 633 participants (365 in the testosterone group and 268 in the control group). |
||||
|
<br> |
||||
Write
Preview
Loading…
Cancel
Save